Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab-Reference-Cited by-同舟云学术

Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab

Published:2019-05 Issue:5 Volume:12 Page:739-748
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Economopoulou Panagiota^ORCID,Kotoula Vassiliki,Koliou Georgia-Angeliki,Papadopoulou Kyriaki,Christodoulou Christos,Pentheroudakis George,Lazaridis Georgios,Arapantoni-Dadioti Petroula,Koutras Angelos,Bafaloukos Dimitris,Papakostas Pavlos,Patsea Helen,Pavlakis Kitty,Pectasides Dimitrios,Kotsakis Athanasios,Razis Evangelia,Aravantinos Gerasimos,Samantas Epaminondas,Kalogeras Konstantine T.,Economopoulos Theofanis,Psyrri Amanta,Fountzilas George

Funder

F. Hoffmann-La Roche

HeCOG research grant (HE TRANS_BR)

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference51 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

3. Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer;Madrid-Paredes;Breast Cancer Res Treat,2015

4. Src in cancer: deregulation and consequences for cell behaviour;Frame;Biochim Biophys Acta,1602

5. Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways;Hosford;Pharmgenomics Pers Med,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK2 Loss Arising From Tumor-Spread-Through-Air-Spaces (STAS) Promotes Tumor Progression by Suppressing CD8+ T Cells in Lung Adenocarcinoma: A Machine Learning Approach;Journal of Korean Medical Science;2024

2. Low CDKN1B Expression Associated with Reduced CD8+ T Lymphocytes Predicts Poor Outcome in Breast Cancer in a Machine Learning Analysis;Journal of Personalized Medicine;2023-12-25

3. Genes, Related to Trastuzumab and Lapatinib Resistance in Breast Cancer: Bioinformatic Analysis and Comprehensive Review;2023 IEEE Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB);2023-09-28

4. mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab;Oncology Letters;2021-11-17

5. Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer;Anticancer Research;2021-04